VIRGINIA RETIREMENT SYSTEMS ET AL - BIO-TECHNE CORP ownership

BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 276 filers reported holding BIO-TECHNE CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

About BIO-TECHNE CORP

Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.

Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.

In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.

Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.

Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
VIRGINIA RETIREMENT SYSTEMS ET AL ownership history of BIO-TECHNE CORP
ValueSharesWeighting
Q2 2021$810,000
-57.6%
1,800
-64.0%
0.01%
-57.9%
Q1 2021$1,910,000
+25.3%
5,000
+4.2%
0.02%
+18.8%
Q4 2020$1,524,000
+28.2%
4,8000.0%0.02%
+14.3%
Q3 2020$1,189,000
-16.6%
4,800
-11.1%
0.01%
-17.6%
Q2 2020$1,426,000
+53.5%
5,400
+10.2%
0.02%
+30.8%
Q1 2020$929,000
-40.4%
4,900
-31.0%
0.01%
-23.5%
Q4 2019$1,559,000
+44.9%
7,100
+29.1%
0.02%
+41.7%
Q3 2019$1,076,000
-2.6%
5,500
+3.8%
0.01%
-7.7%
Q2 2019$1,105,000
-33.8%
5,300
-36.9%
0.01%
-35.0%
Q1 2019$1,668,000
+0.2%
8,400
-27.0%
0.02%
-9.1%
Q4 2018$1,664,000
-29.7%
11,500
-0.9%
0.02%
-18.5%
Q3 2018$2,368,000
+86.2%
11,600
+34.9%
0.03%
+68.8%
Q2 2018$1,272,000
+266.6%
8,600
+273.9%
0.02%
+300.0%
Q1 2018$347,000
-81.8%
2,300
-84.4%
0.00%
-81.8%
Q4 2017$1,904,000
-13.9%
14,700
-19.7%
0.02%
-18.5%
Q3 2017$2,212,000
-14.0%
18,300
-16.4%
0.03%
-15.6%
Q2 2017$2,573,000
+56.2%
21,900
+35.2%
0.03%
+52.4%
Q1 2017$1,647,000
+45.6%
16,200
+47.3%
0.02%
+31.2%
Q4 2016$1,131,000
-9.4%
11,000
-3.5%
0.02%
-11.1%
Q3 2016$1,248,000
+163.3%
11,400
+171.4%
0.02%
+157.1%
Q2 2016$474,000
-29.3%
4,200
-38.2%
0.01%
-30.0%
Q2 2015$670,000
-55.2%
6,800
-54.4%
0.01%
-56.5%
Q1 2015$1,494,000
+8.5%
14,9000.0%0.02%
+9.5%
Q4 2014$1,377,00014,9000.02%
Other shareholders
BIO-TECHNE CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 46,500$16,119,0008.75%
Montanaro Asset Management Ltd 93,950$32,567,0004.90%
Jackson Square Partners, LLC 556,157$192,786,0004.50%
STONE RUN CAPITAL, LLC 22,405$7,767,0003.91%
Ownership Capital B.V. 655,654$227,276,0003.90%
Brown Capital Management 839,587$291,034,0003.90%
Sandhill Capital Partners LLC 97,382$33,757,0003.61%
DF DENT & CO INC 684,026$237,111,0003.34%
Westwind Capital 27,946$9,687,0003.17%
MAIRS & POWER INC 655,930$227,371,0002.72%
View complete list of BIO-TECHNE CORP shareholders